ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00130897
Expanded Access Status : Approved for marketing
First Posted : August 16, 2005
Last Update Posted : March 9, 2012
Sponsor:
Information provided by (Responsible Party):
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
  Expanded Access Status : Approved for marketing
  Actual Primary Completion Date : November 2011
  Actual Study Completion Date : November 2011
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):